iRay Technology Co Ltd
iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-r… Read more
iRay Technology Co Ltd (688301) - Net Assets
Latest net assets as of September 2025: CN¥6.07 Billion CNY
Based on the latest financial reports, iRay Technology Co Ltd (688301) has net assets worth CN¥6.07 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥11.33 Billion) and total liabilities (CN¥5.26 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥6.07 Billion |
| % of Total Assets | 53.59% |
| Annual Growth Rate | 48.16% |
| 5-Year Change | 76.41% |
| 10-Year Change | N/A |
| Growth Volatility | 155.72 |
iRay Technology Co Ltd - Net Assets Trend (2015–2024)
This chart illustrates how iRay Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for iRay Technology Co Ltd (2015–2024)
The table below shows the annual net assets of iRay Technology Co Ltd from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.65 Billion | +6.74% |
| 2023-12-31 | CN¥4.35 Billion | +11.51% |
| 2022-12-31 | CN¥3.90 Billion | +26.89% |
| 2021-12-31 | CN¥3.08 Billion | +16.81% |
| 2020-12-31 | CN¥2.63 Billion | +518.83% |
| 2019-12-31 | CN¥425.61 Million | +28.57% |
| 2018-12-31 | CN¥331.02 Million | +31.66% |
| 2017-12-31 | CN¥251.42 Million | +41.49% |
| 2016-12-31 | CN¥177.70 Million | +31.70% |
| 2015-12-31 | CN¥134.92 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to iRay Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5527.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.89 Billion | 40.78% |
| Common Stock | CN¥143.06 Million | 3.08% |
| Other Comprehensive Income | CN¥371.24 Million | 8.00% |
| Other Components | CN¥2.23 Billion | 48.14% |
| Total Equity | CN¥4.64 Billion | 100.00% |
iRay Technology Co Ltd Competitors by Market Cap
The table below lists competitors of iRay Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jet2 plc
PINK:DRTGF
|
$2.31 Billion |
|
Visteon Corp
NASDAQ:VC
|
$2.31 Billion |
|
Bosideng International Holdings Limited
F:3BD
|
$2.31 Billion |
|
Loncin Motor Co Ltd
SHG:603766
|
$2.31 Billion |
|
Life Insurance Corporation Of India
NSE:LICI
|
$2.30 Billion |
|
Frasers Logistics & Commercial Trust
PINK:FRLOF
|
$2.30 Billion |
|
EZconn Corp
TW:6442
|
$2.30 Billion |
|
Country Garden Holdings Company Ltd
PINK:CTRYF
|
$2.30 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in iRay Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,330,419,315 to 4,638,669,812, a change of 308,250,497 (7.1%).
- Net income of 465,176,808 contributed positively to equity growth.
- Dividend payments of 257,603,617 reduced retained earnings.
- Share repurchases of 19,852,466 reduced equity.
- Other comprehensive income increased equity by 15,054,982.
- Other factors increased equity by 105,474,790.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥465.18 Million | +10.03% |
| Dividends Paid | CN¥257.60 Million | -5.55% |
| Share Repurchases | CN¥19.85 Million | -0.43% |
| Other Comprehensive Income | CN¥15.05 Million | +0.32% |
| Other Changes | CN¥105.47 Million | +2.27% |
| Total Change | CN¥- | 7.12% |
Book Value vs Market Value Analysis
This analysis compares iRay Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.74x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 34.31x to 3.74x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥3.40 | CN¥116.74 | x |
| 2018-12-31 | CN¥4.31 | CN¥116.74 | x |
| 2019-12-31 | CN¥4.19 | CN¥116.74 | x |
| 2020-12-31 | CN¥25.93 | CN¥116.74 | x |
| 2021-12-31 | CN¥30.05 | CN¥116.74 | x |
| 2022-12-31 | CN¥38.04 | CN¥116.74 | x |
| 2023-12-31 | CN¥29.80 | CN¥116.74 | x |
| 2024-12-31 | CN¥31.21 | CN¥116.74 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently iRay Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.03%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 25.40%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 1.96x
- Recent ROE (10.03%) is below the historical average (16.57%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 14.03% | 8.89% | 1.19x | 1.33x | CN¥5.44 Million |
| 2016 | 24.07% | 16.72% | 0.98x | 1.47x | CN¥25.00 Million |
| 2017 | 21.62% | 15.28% | 0.93x | 1.52x | CN¥29.21 Million |
| 2018 | 18.38% | 13.79% | 0.89x | 1.49x | CN¥27.62 Million |
| 2019 | 22.65% | 17.65% | 0.78x | 1.64x | CN¥53.85 Million |
| 2020 | 8.44% | 28.34% | 0.27x | 1.10x | CN¥-41.11 Million |
| 2021 | 15.86% | 40.77% | 0.34x | 1.16x | CN¥178.82 Million |
| 2022 | 16.54% | 41.40% | 0.27x | 1.50x | CN¥253.63 Million |
| 2023 | 14.03% | 32.59% | 0.25x | 1.73x | CN¥174.46 Million |
| 2024 | 10.03% | 25.40% | 0.20x | 1.96x | CN¥1.31 Million |
Industry Comparison
This section compares iRay Technology Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,246,530,775
- Average return on equity (ROE) among peers: 12.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| iRay Technology Co Ltd (688301) | CN¥6.07 Billion | 14.03% | 0.87x | $2.31 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $2.03 Billion | -9.26% | 2.64x | $356.80 Million |
| Blue Sail Medical Co Ltd (002382) | $10.54 Billion | 10.97% | 0.61x | $763.05 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $2.12 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $346.13 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $234.74 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $784.88 Million |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $545.42 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.41 Billion | 16.14% | 0.58x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.62 Billion |
| Autek China Inc (300595) | $105.24 Million | 28.59% | 0.10x | $1.21 Billion |